Print Page  Close Window

Investor Relations Home

Company Overview

NeuroMetrix is a medical device company focused on the neurological complications of diabetes. Its products typically consist of a medical device and consumable biosensors. The Company believes that there are large and important unmet needs in both the diagnosis and treatment of diabetic neuropathies. It is uniquely positioned to address these needs due to its decade-long experience in developing devices that measure and alter peripheral nerve function.More >>

NURO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.01
Change (%) Stock is Up 0.01 (0.50%)
Volume22,279
Data as of 06/19/13 4:00 p.m. ET
Minimum 20 minute delay - Refresh quote
Upcoming Events
There are currently no events scheduled.
Recent NewsMore News >>
DateTitle 
06/10/13NeuroMetrix to Exhibit at American Diabetes Association’s 73rd Scientific SessionsPrinter Friendly Version
06/04/13NeuroMetrix Announces $5 Million Preferred Stock PlacementPrinter Friendly Version
04/25/13NeuroMetrix Reports Q1 2013 ResultsPrinter Friendly Version
04/24/13NeuroMetrix to Partner with Omron Healthcare for Distribution of NC-stat DPNCheck in JapanPrinter Friendly Version
Featured Report
Download Documentation 2012 10-K
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever NeuroMetrix Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.